BIOMAT Database Logo BIOMAT Database Logo

Intralesional bleomycin for acquired immunodeficiency syndrome-associated cutaneous Kaposi's sarcoma. 1995

S Poignonec, and L D Lachiver, and G Lamas, and A Coutellier, and E Caumes, and J Soudant

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012514 Sarcoma, Kaposi A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. Kaposi Sarcoma,Kaposi's Sarcoma,Multiple Idiopathic Pigmented Hemangiosarcoma,Kaposis Sarcoma,Sarcoma, Kaposi's

Related Publications

S Poignonec, and L D Lachiver, and G Lamas, and A Coutellier, and E Caumes, and J Soudant
Cutaneous acquired immunodeficiency syndrome-associated Kaposi's sarcoma in pediatric patients.
June 1990, Archives of dermatology,
S Poignonec, and L D Lachiver, and G Lamas, and A Coutellier, and E Caumes, and J Soudant
[Kaposi's sarcoma associated with acquired immunodeficiency syndrome].
January 1991, Journal des maladies vasculaires,
S Poignonec, and L D Lachiver, and G Lamas, and A Coutellier, and E Caumes, and J Soudant
Pulsed-dye laser therapy for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome.
October 1992, Journal of the American Academy of Dermatology,
S Poignonec, and L D Lachiver, and G Lamas, and A Coutellier, and E Caumes, and J Soudant
Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection.
January 1993, Journal of the American Academy of Dermatology,
S Poignonec, and L D Lachiver, and G Lamas, and A Coutellier, and E Caumes, and J Soudant
Cutaneous cryptococcosis simulating Kaposi's sarcoma in the acquired immunodeficiency syndrome.
March 1990, Cutis,
S Poignonec, and L D Lachiver, and G Lamas, and A Coutellier, and E Caumes, and J Soudant
Local therapies for cutaneous Kaposi's sarcoma in patients with acquired immunodeficiency syndrome.
October 1991, Archives of dermatology,
S Poignonec, and L D Lachiver, and G Lamas, and A Coutellier, and E Caumes, and J Soudant
Acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Biology and management.
March 1997, The Medical clinics of North America,
S Poignonec, and L D Lachiver, and G Lamas, and A Coutellier, and E Caumes, and J Soudant
Acquired immunodeficiency syndrome-related Kaposi's sarcoma.
September 1995, Mayo Clinic proceedings,
S Poignonec, and L D Lachiver, and G Lamas, and A Coutellier, and E Caumes, and J Soudant
Acquired immunodeficiency syndrome and Kaposi's sarcoma.
February 1985, Journal of the Royal Society of Medicine,
S Poignonec, and L D Lachiver, and G Lamas, and A Coutellier, and E Caumes, and J Soudant
Kaposi's sarcoma--an acquired immunodeficiency syndrome.
February 1984, The Ohio State medical journal,
Copied contents to your clipboard!